Akèy › Ipòparatiwoïdism › Nevada
Etid klinik pou Ipòparatiwoïdism nan Nevada
3 etid pou Ipòparatiwoïdism ap chèche patisipan nan sit nan Nevada.
Vil nan Nevada
Tèks ofisyèl etid la (Anglè)
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Reno
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07081997A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
- MBX Biosciences Investigational Site, Las Vegas
- MBX Biosciences Investigational Site, Reno
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07699471Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site, Reno
Ap rekriteFaz 3
Laj 16 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07805356Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.